Follow
Vathany Kulasingam
Vathany Kulasingam
University Health Network
Verified email at uhn.ca
Title
Cited by
Cited by
Year
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
V Kulasingam, EP Diamandis
Nature clinical practice Oncology 5 (10), 588-599, 2008
8902008
Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients
VG Hall, VH Ferreira, T Ku, M Ierullo, B Majchrzak-Kita, C Chaparro, ...
New England Journal of Medicine 385 (13), 1244-1246, 2021
5462021
Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets
V Kulasingam, EP Diamandis
Molecular & cellular proteomics 6 (11), 1997-2011, 2007
2402007
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer
V Kulasingam, MP Pavlou, EP Diamandis
Nature Reviews Cancer 10 (5), 371-378, 2010
1912010
Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines
C Planque, V Kulasingam, CR Smith, K Reckamp, L Goodglick, ...
Molecular & cellular proteomics 8 (12), 2746-2758, 2009
1702009
Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers* S
C Kuk, V Kulasingam, CG Gunawardana, CR Smith, I Batruch, ...
Molecular & Cellular Proteomics 8 (4), 661-669, 2009
1622009
Quantitative measurement of anti-SARS-CoV-2 antibodies: analytical and clinical evaluation
V Higgins, A Fabros, V Kulasingam
Journal of clinical microbiology 59 (4), 10.1128/jcm. 03149-20, 2021
1342021
Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
VG Hall, VH Ferreira, M Ierullo, T Ku, T Marinelli, B Majchrzak-Kita, ...
American Journal of Transplantation 21 (12), 3980-3989, 2021
1322021
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma …
B Krastins, A Prakash, DA Sarracino, D Nedelkov, EE Niederkofler, ...
Clinical biochemistry 46 (6), 399-410, 2013
1252013
Circulating tumor DNA as a cancer biomarker: fact or fiction?
F Leung, V Kulasingam, EP Diamandis, DSB Hoon, K Kinzler, K Pantel, ...
Clinical chemistry 62 (8), 1054-1060, 2016
1042016
Tissue culture‐based breast cancer biomarker discovery platform
V Kulasingam, EP Diamandis
International journal of cancer 123 (9), 2007-2012, 2008
982008
“Product ion monitoring” assay for prostate-specific antigen in serum using a linear ion-trap
V Kulasingam, CR Smith, I Batruch, A Buckler, DA Jeffery, EP Diamandis
Journal of proteome research 7 (2), 640-647, 2008
962008
Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses
VG Hall, VH Ferreira, H Wood, M Ierullo, B Majchrzak-Kita, K Manguiat, ...
Nature Immunology 23 (3), 380-385, 2022
892022
Platform for establishing interlaboratory reproducibility of selected reaction monitoring-based mass spectrometry peptide assays
A Prakash, T Rezai, B Krastins, D Sarracino, M Athanas, P Russo, ...
Journal of proteome research 9 (12), 6678-6688, 2010
822010
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer
V Kulasingam, Y Zheng, A Soosaipillai, AE Leon, M Gion, EP Diamandis
International journal of cancer 125 (1), 9-14, 2009
812009
Validation of a novel biomarker panel for the detection of ovarian cancer
F Leung, MQ Bernardini, MD Brown, Y Zheng, R Molina, RC Bast Jr, ...
Cancer Epidemiology, Biomarkers & Prevention 25 (9), 1333-1340, 2016
782016
Folate-receptor 1 (FOLR1) protein is elevated in the serum of ovarian cancer patients
F Leung, A Dimitromanolakis, H Kobayashi, EP Diamandis, V Kulasingam
Clinical biochemistry 46 (15), 1462-1468, 2013
762013
Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies
A Prakash, T Rezai, B Krastins, D Sarracino, M Athanas, P Russo, ...
Journal of proteome research 11 (8), 3986-3995, 2012
762012
Pediatric reference intervals for 28 chemistries and immunoassays on the Roche cobasŪ 6000 analyzer—A CALIPER pilot study
V Kulasingam, BP Jung, IM Blasutig, S Baradaran, MK Chan, M Aytekin, ...
Clinical biochemistry 43 (13-14), 1045-1050, 2010
672010
Urinary adenosine excretion in type 1 diabetes
H Rajasekeran, Y Lytvyn, A Bozovic, JA Lovshin, E Diamandis, D Cattran, ...
American Journal of Physiology-Renal Physiology 313 (2), F184-F191, 2017
632017
The system can't perform the operation now. Try again later.
Articles 1–20